HPV detection methods and genotyping techniques in screening for cervical cancer

Annales de Pathologie

Volumn 32, Issue 6, 2012, Pages

  Eide, Maj Liv ^a   Debaque, Hervé ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b SCP des Drs Bloget et Declerck   (France)

Author keywords

Genotyping; Human papillomavirus (HPV); Hybridization; Oncogenic; PCR (Polymerase Chain Reaction)

Indexed keywords

COMPLEMENTARY RNA; MESSENGER RNA; VIRUS DNA;

ALGORITHM; CANCER SCREENING; CLINICAL DECISION MAKING; CONSENSUS; CYTOLOGY; DNA MICROARRAY; GENE AMPLIFICATION; GENOTYPING TECHNIQUE; HYBRIDIZATION; LABORATORY DIAGNOSIS; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; SHORT SURVEY; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS GENOME; WART VIRUS;

ALPHAPAPILLOMAVIRUS; BETAPAPILLOMAVIRUS; DNA, VIRAL; FEMALE; GENOME, VIRAL; GENOTYPING TECHNIQUES; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MASS SCREENING; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; REAGENT KITS, DIAGNOSTIC; RNA, MESSENGER; RNA, VIRAL; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS;

EID: 84871022319     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annpat.2012.09.231     Document Type: Short Survey

References (23)

1. Shuman A.G., Wolf G.T. Human papillomavirus status in head and neck cancer: the ethics of disclosure. Cancer 2010, 116:4221-4226.
2. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
3. Prétet J.L., Jacquard A.C., Carcopino X., Charlot J.F., Bouhour D., Kantelip B., et al. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study; EDITH study group. Int J Cancer 2008, 122:428-432.
4. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., et al. A review of human carcinogens-Part B: biological agents, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group. Lancet Oncol 2009, 10:321-322.
5. Munoz N., Castellsague X., Berrington de González A., Gissmann L. HPV in the etiology of human cancer. Vaccine 2006, 24S3. S3/1-10.
6. Wiebren A.T., Fiander A., Reich O., Powell N., Nowakowski A.M., Kirschner B., et al. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer 2012, 10.1002/ijc.27713.
7. Ferlay J., Parkin D.M., Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010, 46:765-781.
8. Duport N. Données épidémiologiques sur le cancer du col de l'utérus - état des connaissances - Actualisation 2008 - Institut de veille sanitaire. http://www.pasteur.fr/ip/resource/filecenter/document/01s-00004i-00u/cancer-col-uterus-2008.pdf.
9. Szarewski A., Mesher D., Cadman L., Austin J., Ashdown-Barr L., Ho L., et al. Comparison of seven tests for high grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study. J Clin Microbiol 2012, 50:1867-1873.
10. Ovestad I.T., Vennestrøm U., Andersen L., Gudlaugsson E., Munk A.C., Malpica A., et al. Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3. Gynecol Oncol 2011, 123:278-283.
11. Haute Autorité de santé (HAS) Conditions de réalisation de la détection des HPV-Note de cadrage. Juin 2012; http://www.has-sante.fr/.
12. Wentzensen N., Gravitt P.E., Solomon D., Wheeler C.M., Castle P.E. A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study. Cancer Epidemiol Biomarkers Prev 2009, 18:1341-1349.
13. Castle P.E., Stoler M.H., Wright T.C., Sharma A., Wright T.L., Behrens C.M. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol 2011, 12:880-890.
14. Origoni M., Carminati G., Rolla S., Clementi M., Sideri M., Sandri M.T., et al. Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology. Eur J Clin Microbiol Infect Dis 2012, 31:2401-2406.
15. ® technology Ha Thai. J Clin Virol 2009, 45:S1. [S93 S97].
16. Wong O.G., Lo C.K., Szeto E., Cheung A.N. Efficacy of Abbott Real Time High Risk HPV test in evaluation of atypical squamous cells of undetermined significance from an Asian screening population. J Clin Virol 2011, 51:136-138.
17. Youens K.E., Hosler G.A., Washington P.J., Jenevein E.P., Murphy K.M. Clinical experience with the Cervista HPV HR assay: correlation of cytology and HPV status from 56,501 specimens. J Mol Diagn 2011, 13:160-166.
18. Galan-Sanchez F., Hernández-Menendez M., De Los Rios Hernandez M.A., Rodriguez-Iglesias M. Performance of the New INNO-LiPA HPV extra to genotype human papillomavirus in cervical cell specimens. Acta Cytol 2011, 55:341-343.
19. ® assay with the digene HC2 HPV DNA assay for the detection of 13 high-risk human papillomaviruses in cervical and anal scrapes. J Med Virol 2011, 83:1377-1382.
20. Pista A., Verdasca N., Oliveira A. Clinical performance of the CLART human papillomavirus 2 assay compared with the hybrid capture 2 test. J Med Virol 2011, 83:272-276.
21. Deng X.M., Liu M., Zheng G.X., Wang C.X., Zhang J., Li W. Evaluation of genotyping of human papillomavirus by a new DNA liquid chip based on Luminex XMAP. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2009, 23:476-478.
22. Burger E.A., Kornør H., Klemp M., Lauvrak V., Kristiansen I.S. HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review. Gynecol Oncol 2011, 120:430-438.
23. Saslow, et al. Screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012, 137:516-542.